NovaBay Pharmaceuticals Inc. (NBY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NovaBay Pharmaceuticals I...

    AMEX: NBY · Real-Time Price · USD
    1.36
    -0.17 (-11.11%)
    At close: Oct 03, 2025, 3:59 PM
    1.36
    0.00%
    After-hours: Oct 03, 2025, 07:56 PM EDT

    NovaBay Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 430K 3.13M 5.36M 7.5M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 477K n/a 484K 475K
    Other Long-Term Assets
    		 3K 497K 489K 476K
    Receivables
    		 389K 759K 1.97M 1.67M
    Inventory
    		 765K 2.88M 3.44M 3.22M
    Other Current Assets
    		 158K 81K 159K 129K
    Total Current Assets
    		 1.94M 7.15M 11.33M 13.17M
    Property-Plant & Equipment
    		 1.01M 1.38M 1.95M 604K
    Goodwill & Intangibles
    		 n/a n/a 2.63M 9.73M
    Total Long-Term Assets
    		 1.49M 1.88M 5.07M 10.81M
    Total Assets
    		 3.42M 9.03M 16.4M 23.98M
    Account Payables
    		 623K 1.13M 1.08M 1.04M
    Deferred Revenue
    		 488K n/a 1.81M 1.29M
    Short-Term Debt
    		 565K 1.14M 453K 305K
    Other Current Liabilities
    		 172K 1.18M 406K 320K
    Total Current Liabilities
    		 2.84M 4.28M 4.26M 3.44M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 334K n/a 10.12M
    Total Long-Term Liabilities
    		 709K 1.44M 1.59M 10.37M
    Total Liabilities
    		 3.55M 5.72M 5.84M 13.81M
    Total Debt
    		 1.67M 2.74M 2.04M 551K
    Book Value
    		 -129K 3.31M 10.55M 10.17M
    Book Value Per Share
    		 -0.04 27.62 351.79 321.50
    Common Stock
    		 49K 112K 652K 478K
    Retained Earnings
    		 -183.46M -174.85M -158.15M -141.89M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -129K 3.31M 10.55M 10.17M
    Total Investments
    		 477K 476K 484K 475K

    Add to Watchlist